| IPO: a tool for automated optimization of XCMS parameters G Libiseller, M Dvorzak, U Kleb, E Gander, T Eisenberg, F Madeo, ... BMC bioinformatics 16, 1-10, 2015 | 334 | 2015 |
| Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,®/Doxil®—a cerebral open … T Birngruber, R Raml, W Gladdines, C Gatschelhofer, E Gander, A Ghosh, ... Journal of pharmaceutical sciences 103 (7), 1945-1948, 2014 | 107 | 2014 |
| Polyamines in biological samples: Rapid and robust quantification by solid-phase extraction online-coupled to liquid chromatography–tandem mass spectrometry C Magnes, A Fauland, E Gander, S Narath, M Ratzer, T Eisenberg, ... Journal of chromatography A 1331, 44-51, 2014 | 76 | 2014 |
| An untargeted metabolomics approach to characterize short-term and long-term metabolic changes after bariatric surgery SH Narath, SI Mautner, E Svehlikova, B Schultes, TR Pieber, FM Sinner, ... PloS one 11 (9), e0161425, 2016 | 65 | 2016 |
| Effect of ceramide on nonraft proteins G Pabst, B Boulgaropoulos, E Gander, BR Sarangi, H Amenitsch, ... Journal of Membrane Biology 231, 125-132, 2009 | 19 | 2009 |
| Biomarker for the diagnosis of pulmonary hypertension (PH) N Bordag, C Magnes, S Narath, E Gander, A Olschewski, BM Nagy, ... US Patent 11,275,093, 2022 | | 2022 |
| Metabolic fingerprinting in pulmonary hypertension B Nagy, N Bordag, C Nagaraj, V Foris, A Tornyos, S Narath, E Gander, ... WIENER KLINISCHE WOCHENSCHRIFT 130 (19-20), 604-605, 2018 | | 2018 |
| Biomarker for the diagnosis of pulmonary hypertension (ph) N Bordag, C Magnes, S NARATH, E GANDER, A OLSCHEWSKI, ... | | 2017 |
| Metabolic phenotyping of first degree relatives of patients with type 1 diabetes EE Zügner, G Treiber, B Prietl, E Gander, N Bordag, C Magnes, TR Pieber | | 2017 |
